Loading...
AFP and eGFR are related to early and late recurrence of HCC following antiviral therapy
BACKGROUND: An unexpected recurrence of hepatocellular carcinoma (HCC) sometimes occurs in patients with hepatitis C virus (HCV) after treatment with direct-acting antivirals (DAAs). However, the characteristics of patients with HCC recurrence may differ depending on time after DAA treatment. We aim...
Saved in:
| Published in: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8201700/ https://ncbi.nlm.nih.gov/pubmed/34126947 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-021-08401-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|